Alternate routes of protein, peptide & vaccine delivery via oral, pulmonary, ocular and transdermal methods
Biologic therapy has revolutionized the medical treatment landscape. However, simplicity and ease of administration remains a challenge to achieve long-term patient compliance and optimal therapeutic outcomes. Given the high cost of biologic therapies, it is the duty of pharmaceutical companies to develop non-invasive formulations that improve patient acceptance and efficacy. Partnerships are an increasingly attractive pathway for accelerating development from basic biological understanding to formulation considerations.
Academic and industry drug delivery experts will share the current challenges and opportunities with alternate routes of delivering large molecules orally, via inhalation, using microneedles and minimally invasive methods for ocular delivery. Two case studies for oral delivery of large molecules will also be shared during the 60 minutes webinar. Q&A session will then follow.
